company background image
SANP logo

Sanofi BATS-CHIXE:SANP Stock Report

Last Price

€88.54

Market Cap

€111.9b

7D

0%

1Y

-8.6%

Updated

25 Mar, 2024

Data

Company Financials +

SANP Stock Overview

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

SANP fundamental analysis
Snowflake Score
Valuation6/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Sanofi Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi
Historical stock prices
Current Share Price€88.54
52 Week High€104.93
52 Week Low€80.89
Beta0.44
1 Month Change-1.14%
3 Month Change-0.48%
1 Year Change-8.57%
3 Year Change4.99%
5 Year Change11.96%
Change since IPO51.99%

Recent News & Updates

Recent updates

Shareholder Returns

SANPGB PharmaceuticalsGB Market
7D0%1.3%2.1%
1Y-8.6%-0.5%3.8%

Return vs Industry: SANP underperformed the UK Pharmaceuticals industry which returned -0.1% over the past year.

Return vs Market: SANP underperformed the UK Market which returned 4.2% over the past year.

Price Volatility

Is SANP's price volatile compared to industry and market?
SANP volatility
SANP Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement9.3%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.2%
10% least volatile stocks in GB Market2.5%

Stable Share Price: SANP has not had significant price volatility in the past 3 months.

Volatility Over Time: SANP's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197386,088Paul Hudsonhttps://www.sanofi.com

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
SANP fundamental statistics
Market cap€111.93b
Earnings (TTM)€5.40b
Revenue (TTM)€46.03b

20.5x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SANP income statement (TTM)
Revenue€46.03b
Cost of Revenue€14.22b
Gross Profit€31.82b
Other Expenses€26.42b
Earnings€5.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)4.32
Gross Margin69.12%
Net Profit Margin11.73%
Debt/Equity Ratio22.0%

How did SANP perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

87%

Payout Ratio

Does SANP pay a reliable dividends?

See SANP dividend history and benchmarks
When do you need to buy SANP by to receive an upcoming dividend?
Sanofi dividend dates
Ex Dividend DateMay 13 2024
Dividend Pay DateMay 15 2024
Days until Ex dividend47 days
Days until Dividend pay date49 days

Does SANP pay a reliable dividends?

See SANP dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.